Navigation Links
NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting
Date:3/4/2009

Product Candidate NVC-422 Demonstrates Ability to Treat Subcutaneous Infections

EMERYVILLE, Calif., March 4 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Alternext: NBY), a clinical stage biopharmaceutical company, today announced that new preclinical data related to NVC-422, the lead molecule in NovaBay's, proprietary Aganocide(R) class of compounds, will be presented at the American Academy of Dermatology (AAD) 67th Annual Meeting in San Francisco during March 6-10, 2009. NovaBay is focused on developing first-in-class, novel, synthetic anti-infective product candidates that are bioequivalent to the active antimicrobial molecules generated within white blood cells for the treatment and prevention of bacterial, fungal, and viral infections without developing resistance.

"We have new data at the upcoming AAD annual meeting that further demonstrate the potential of NVC-422 and our Aganocide class of compounds to effectively treat chronic and common fungal skin infections," said Dr. Ron Najafi, chairman and chief executive officer. "Data from the Center for Medical Mycology at Case Western Reserve University Hospitals confirm how our novel, anti-infective agent in an animal model is highly effective not only on the skin surface, but also showed potent ability to kill subcutaneous organisms by route of the hair follicles."

Following are the details on the poster presentation.

    Saturday, March 7
    Poster Title: "Efficacy of NVC 422 in the Topical Treatment of
    Dermatophytosis in a Guinea Pig Model"
    Professor Mahmoud Ghannoum et al
    Time: 9:20 a.m. Pacific Time
    Moscone Center North, Hall E, Abstract #2405

About NVC-422

NVC-422 is the lead molecule in NovaBay's Aganocide class of compounds. NVC-422 is a non-antibiotic, stable analog of an anti-infective molecule produced by white blood cells. NovaBay b
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NovaBay Pharmaceuticals Closes Initial Public Offering of Common Stock
2. NovaBay announces third quarter 2007 financial results
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
10. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... 2014: Daily fruit consumption cuts the risk of cardiovascular ... presented at ESC Congress today by Dr Huaidong Du ... follow-up study of nearly 0.5 million people in the ... ate, the more their risk of CVD declined. , ... and stroke, is the leading cause of death worldwide. ...
(Date:9/1/2014)... Springs, LA (PRWEB) September 01, 2014 ... Intervention Instructor training, Derek is currently pursuing counselor certification ... able to advance through the CPI training program as ... states "and I have grown both personally and professionally. ... permanently recover, I am competently able to do so. ...
(Date:9/1/2014)... BCC Research ( http://www.bccresearch.com ) reveals in ... GLOBAL MARKETS , the global market for blood-brain barrier ... expected to reach $38.7 million in 2014. This is ... which is equivalent to 64.9% compound annual growth rate ... segment is forecasted to grow at a CAGR of ...
(Date:9/1/2014)... In honor of National Take Your Cat to the ... Referral Center of Minnesota (AERC) is offering a few reasons why ... , Many people don’t take their cat to the vet because ... they wouldn’t decide not to take their kid to dentist because ... goes for pets. Just like people want their loved ones to ...
(Date:9/1/2014)... Registration is now open for the 4th Annual Harmon Meadow ... held on Sunday, September 21, 2014. The event will be ... Secaucus, New Jersey. All proceeds from the race will benefit ... a sense of self, restoring the family unit, and restoring ... General registration is $30 with special pricing for veterans, military ...
Breaking Medicine News(10 mins):Health News:Fruit consumption cuts CVD risk by up to 40 percent 2Health News:Fruit consumption cuts CVD risk by up to 40 percent 3Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 3Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 3Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2
... infections of the brain, which can cause epileptic ... bordering southwestern states, Loyola University Health System researchers ... of the population may have the infection, neurocysticercosis. ... "remains a serious health concern, especially among the ...
... of a nationwide recession, a genetics research laboratory on Rutgers, ... continued success of the Rutgers University Cell and ... as a world leader in human disease and genome studies, ... and foundation grants that benefit the economy throughout the region. ...
... therapy, study found , WEDNESDAY, April 14 (HealthDay News) ... for developing blood clots, especially if they,re undergoing hormone ... it is important to consider thromboembolic [blood-clotting] side effects ... require endocrine treatment," said Mieke van Hemelrijck, lead author ...
... ... the increasing need for qualified nurses, Medi-Smart.com -- a site providing nursing education resources ... and feel designed to enhance user navigation, Medi-Smart now offers downloadable guides, videos, infographics, ... ...
... ... irritable bowel syndrome (IBS). Dr. David Blyweiss in Boca Raton, FL finds that diet and ... ... population suffers from the abdominal discomfort and altered bowel habits of the puzzling functional disorder ...
... ... PLM technologies, including expanding DesignState capablities as well as offering productized services for PLM. ... CEO and brought in Richard Haner, formerly a partner at Centerpoint Ventures, as Company Chairman. ... (PRWEB) April 14, ...
Cached Medicine News:Health News:Tapeworm brain infection 'serious health concern' 2Health News:Lab that probes genetic clues to disease is poised for major expansion 2Health News:Lab that probes genetic clues to disease is poised for major expansion 3Health News:Prostate Cancer Patients at Higher Risk of Blood Clots 2Health News:Prostate Cancer Patients at Higher Risk of Blood Clots 3Health News:Medi-Smart.com's New Look and Expanded Resources Meet Growing Nursing Employment Needs 2Health News:Dr. David Blyweiss Announces New IBS Relief Protocol 2Health News:Dr. David Blyweiss Announces New IBS Relief Protocol 3Health News:Zero Wait-State Announces New Leadership Team and Strategic Focus 2Health News:Zero Wait-State Announces New Leadership Team and Strategic Focus 3
(Date:8/30/2014)... Mass. , Aug. 30, 2014  Boston ... its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) ... clinical trial investigating vagus nerve stimulation (VNS) for ... M.D., Ph.D., Professor of Therapeutics and Cardiology and ... Institut National de la Sante et de la ...
(Date:8/29/2014)... -- Market Research Report on Global and Chinese ... and in-depth market survey on Global and ... firstly reviews the basic information of X-Ray Crystallography ... The report then explores global and China,s top ... specification, capacity, Production value, and market share etc. ...
(Date:8/29/2014)... HILL, N.C. , Aug. 29, 2014 ... Leaders (KOLs) can be the difference between a product,s ... to effectively map and stratify KOL targets – and ... build the type of strong relationships upon which successful ... research, savvy pharma companies have identified internal inconsistencies in ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5Implementing a Strategic Thought Leader Management & Engagement System 2
... Medical Systems (NYSE: VAR ), a world ... first education center in India to train medical physicists ... systems. The center in Mumbai, equipped ... system for radiotherapy treatment simulations, will enable the country,s ...
... RIVER, Mass., Sept. 1, Millstone Medical Outsourcing ... corporate website at www.millstonemedical.com .  With expanded ... with additional information about Millstone Medical,s services, commitment ... site,s design was intended to mirror the company,s ...
Cached Medicine Technology:Varian Medical Systems Establishes Radiotherapy Training Center in Mumbai, India 2Millstone Medical Outsourcing Launches New, Improved Company Website 2
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... AliMed® Turnbuckle Ankle Orthosis enables ... torque at the ankle joint to ... The splint features a pair of ... and eversion/inversion simultaneously. Simply adjust the ...
Softsplint after bunion surgery. Hook-and-loop closure. Maintains hallux positioning and metatarsophalangeal alignment. Washable....
... As a prophylaxis for deep vein thrombosis, ... combination of graduated sequential compression and rapid ... formation by increasing venous ejection while producing ... System includes a pump with tube assembly ...
Medicine Products: